Rituximab for the first-line treatment of stage III-IV follicular lymphoma

TA243 Follicular lymphoma - rituximab (review): review decision - August 2014 information  

TA243 Follicular lymphoma - rituximab (review): appendix a - decision paper presented to the Institute's Guidance Executive ^{PDF 106.59 KB} 26 August 2014  

TA243 Follicular lymphoma - rituximab (review): review proposal - June 2014 information  

Appendix A: matrix of stakeholders ^{PDF 99.13 KB} 16 June 2014  

Appendix B: proposal paper presented to the Institute's Guidance Executive ^{PDF 444.3 KB} 16 June 2014  

Follicular lymphoma - rituximab (review): EIA ^{PDF 74.53 KB} 25 January 2012  

Follicular lymphoma - rituximab (review): final appraisal determination information  

Follicular lymphoma - rituximab (review): final appraisal determination ^{PDF 231.91 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): response to consultee, commentator and public comments on the appraisal consultation document (ACD) ^{PDF 162.35 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): consultee and commentator comments on the ACD  

Follicular lymphoma - rituximab (review): comments from School of Health and Related Research ^{PDF 51.52 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): comments from Roche Pharmaceuticals ^{PDF 175.19 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): comments from Lymphoma association and Leukaemia Care ^{PDF 60.92 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): comments from Royal College of Physicians ^{PDF 203.56 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): comments from Healthcare Improvement Scotland ^{PDF 62.44 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): comments from Commissioning Support Appraisals Service ^{PDF 375.73 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): expert comments - Parker (clinical expert) ^{PDF 46.95 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): comments on the ACD received from the public through the NICE website ^{PDF 31.17 KB} 01 December 2011  

Follicular lymphoma - rituximab (review): appraisal consultation  

Follicular lymphoma - rituximab (review): appraisal consultation document information  

Follicular lymphoma - rituximab (review): evaluation report  

Follicular lymphoma - rituximab (review): overview ^{PDF 236.37 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): assessment report  

Follicular lymphoma - rituximab (review): assessment report ^{PDF 2.64 MB} 05 September 2011  

Follicular lymphoma - rituximab (review): erratum to assessment report ^{PDF 29.35 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): consultee and commentator comments on the assessment report  

Follicular lymphoma - rituximab (review): Roche ^{PDF 92.41 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): Healthcare Improvement Scotland  

Follicular lymphoma - rituximab (review): Healthcare Improvement Scotland comments 1 ^{PDF 34.05 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): Healthcare Improvement Scotland comments 2 ^{PDF 150.22 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): response to consultee and commentator comments on the assessment report  

Follicular lymphoma - rituximab (review): Assessment Group response to comments from Roche ^{PDF 15.95 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): Assessment Group response to Healthcare Improvement Scotland ^{PDF 37.45 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): Roche executive summary ^{PDF 96.46 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): non-manufacturer submission  

Follicular lymphoma - rituximab (review): Lymphoma Association ^{PDF 36.92 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): Royal College of Pathologists and British Society for Haematology ^{PDF 31.54 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): NHS North of Tyne ^{PDF 30.07 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): expert written personal statements  

Follicular lymphoma - rituximab (review): Barton ^{PDF 1.13 MB} 05 September 2011  

Follicular lymphoma - rituximab (review): Jolliffe ^{PDF 18.69 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): Parker ^{PDF 29.24 KB} 05 September 2011  

Follicular lymphoma - rituximab (review): assessment report consultation ^{PDF 3.74 MB} 25 May 2011  

Follicular lymphoma - rituximab (review): protocol ^{PDF 119.94 KB} 04 October 2010  

Follicular lymphoma - rituximab (review): final scope ^{PDF 69.37 KB} 13 September 2010  

Follicular lymphoma - rituximab (review): final matrix ^{PDF 48.53 KB} 10 September 2010  

Follicular lymphoma - rituximab (review): response to consultee and commentator comments on the draft scope ^{PDF 105.58 KB} 13 September 2010  

Follicular lymphoma - rituximab (review): response to consultee and commentator comments on the provisional matrix of consultees and commentators ^{PDF 28.84 KB} 13 September 2010  

Follicular lymphoma - rituximab (review): appendix A - draft scope ^{PDF 97.45 KB} 27 April 2010  

Follicular lymphoma - rituximab (review): appendix B - provisional matrix of consultees and commentators ^{PDF 38.98 KB} 29 April 2010